Apogee Therapeutics (APGE) Change in Acquisitions & Divestments (2024 - 2026)

Apogee Therapeutics (APGE) has 3 years of Change in Acquisitions & Divestments data on file, last reported at $147.9 million in Q1 2026.

• Change in Acquisitions & Divestments for Q1 2026 came in at $147.9 million, up 28.05% year-over-year; the trailing twelve-month figure through Mar 2026 was $500.3 million (up 27.9% YoY), and the FY2025 annual result was $467.9 million, up 33.62% from the prior year.
• Change in Acquisitions & Divestments improved to $147.9 million in Q1 2026 per APGE's latest filing, from $100.5 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $147.9 million in Q1 2026 and troughed at $74.5 million in Q1 2024.
• A 3-year average of $107.3 million and a median of $107.0 million in 2024 frame the typical range for Change in Acquisitions & Divestments.
• On a YoY basis, Change in Acquisitions & Divestments climbed as much as 61.25% in 2025 and fell as far as 6.01% in 2025.
• A 3-year view of Change in Acquisitions & Divestments shows it stood at $107.0 million in 2024, then dropped by 6.01% to $100.5 million in 2025, then surged by 47.12% to $147.9 million in 2026.
• Business Quant data shows APGE's Change in Acquisitions & Divestments at $147.9 million in Q1 2026, $100.5 million in Q4 2025, and $125.6 million in Q3 2025.